Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Pharmaceutical ETF

+ Add to Watchlist

VEFV:GR

61.9100 EUR 0.3600 0.58%

As of 03:24:40 ET on 03/04/2015.

Snapshot for Market Vectors Pharmaceutical ETF (VEFV)

Open: 61.9100 High - Low: 61.9100 - 61.9100 Primary Exchange: Berlin
Volume: 0 52-Week Range: 39.6100 - 65.1400 Beta vs MVPPHTR: 0.9762

ETF Chart for VEFV

No chart data available.
  • VEFV:GR 61.9100
  • 1D
  • 1M
  • 1Y
61.5500
Interactive VEFV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for VEFV

Market Vectors Pharmaceutical ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Pharmaceutical 25 Index.

Inception Date: 2009-03-20 Telephone: 1-212-293-2000
Managers: PETER LIAO / GEORGE CAO
Web Site: www.vaneck.com

Fundamentals for VEFV

NAV -
Assets (M) (on 2015-03-03) 386.3494
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for VEFV

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-12-29) 0.2439
Dividend Yield (ttm) 1.34%

Performance for VEFV

1-Month +8.12% 1-Year +45.04%
3-Month +14.51% 3-Year +33.92%
Year To Date +15.31% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for VEFV

Filing Date: 03/03/2015
Name Position Value % of Total
Novartis AG 351,402 34,809,882 9.037%
Johnson & Johnson 317,553 32,498,374 8.437%
Pfizer Inc 757,859 26,191,607 6.799%
Valeant Pharmaceuticals Intern 100,288 20,319,352 5.275%
GlaxoSmithKline PLC 418,479 19,965,633 5.183%
Sanofi 396,854 19,080,740 4.953%
Novo Nordisk A/S 397,546 18,772,122 4.873%
Actavis plc 63,287 18,747,508 4.867%
Allergan Inc/United States 77,961 18,309,920 4.753%
Merck & Co Inc 303,429 17,702,048 4.596%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil